Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 2,349 | 687 | 1,663 | 1,231 | 616 |
| Operating Income | -2,349 | -687 | -1,663 | -1,231 | -616 |
| Interest Expense | 31 | 18 | 46 | 43 | 41 |
| Other Income | 0 | -1 | 0 | 4 | 0 |
| Pre-tax Income | -2,379 | -706 | -1,708 | -1,270 | -657 |
| Net Income Continuous | -2,379 | -706 | -1,708 | -1,270 | -657 |
| Net Income | $-2,379 | $-706 | $-1,708 | $-1,270 | $-657 |
| EPS Basic Total Ops | -150.00 | -57.50 | -135.00 | -102.50 | -55.00 |
| EPS Basic Continuous Ops | -150.77 | -56.46 | -135.91 | -102.85 | -53.90 |
| EPS Diluted Total Ops | -150.00 | -57.50 | -135.00 | -102.50 | -55.00 |
| EPS Diluted Continuous Ops | -150.77 | -56.46 | -135.91 | -102.85 | -53.90 |
| EBITDA(a) | $-2,349 | $-687 | $-1,663 | $-1,231 | $-616 |